Skip to main content
Is PLUVICTO Right For Me?
Interest-Based Ads
Live Support is AVAILABLE if you have been prescribed PLUVICTO
PLUVICTO—now available for PSMA+ mCRPC before chemotherapy
If you’ve had hormone therapy, it may be time for PLUVICTO. Learn more about eligibility by clicking the link below.
Important Safety Information
What is the most important information I should know about PLUVICTO?
Use of PLUVICTO involves exposure to radioactivity. Long-term, accruing radiation exposure is associated with an increased risk for cancer. Drink plenty of water and urinate as often as possible during the first hours after administration...
Approved Use
What is PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan)?
PLUVICTO is a prescription treatment used to treat adults with prostate-specific membrane antigen–positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC) already treated with:
- hormone therapy or
- hormone therapy and chemotherapy
Click or scroll to see IMPORTANT SAFETY INFORMATION AND APPROVED USE